Ensysce Biosciences develops opioid pain medicines designed to resist abuse and overdose, based in La Jolla, California. It last closed at $0.36 on Nov 20, down 0.17% on the day. The next earnings report for ENSC is expected around Mon, Mar 29, 2027, after the close. For the quarter ended Sep 2026, ENSC reported EPS of -$4.52 on revenue of $2.2M, with revenue up 342.4% from a year ago. Over its last 8 reports the stock moved an average of 8.3% the session after earnings. Over the last 12 months ENSC insiders bought $444K of stock on the open market and sold $0, according to SEC Form 4 filings.
AI Auto Pilots
Is ENSC in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ENSC.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on ENSCStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
ENSC · as of the Nov 20 close · updated each morning
Downtrend
The stock is 8% below its 20 day and 21% below its 50 day average. It is 12% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 40). The nearest support is the Pivot S1 at $0.35, and the nearest resistance the Pivot R1 at $0.37.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityNormal, 12.0%/day
Key levels
$1.8552 week high+413.9%
$0.4450 day average+22.2%
$0.42Swing high (Aug 26)+16.7%
$0.40100 day average+11.1%
$0.40200 day average+11.1%
$0.3920 day average+8.3%
$0.37Pivot R1+2.8%
$0.36Pivot+0.0%
$0.36Last close
$0.35Pivot S1−2.8%
$0.35Swing low (Aug 24)−2.8%
$0.2352 week low−36.1%
Indicators
RSI (14)
39.64
Weak, oversold below 30
Neutral
MACD
-0.02
Below its signal line
Bearish
Stochastic
42.3
Middle of its range
Neutral
ADX (14)
19.3
No clear trend
Williams %R
-59.4
Oversold below −80, overbought above −20
Neutral
CCI (20)
-69.0
Oversold below −100, overbought above 100
Neutral
Rate of change
+9.5%
Change over 10 sessions
Bullish
ATR (14)
$0.04
Typical daily range, 12.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityNormal, 34.4%/day
Key levels
$1.8552 week high+413.9%
$0.4450 day average+22.2%
$0.42Swing high (Aug 26)+16.7%
$0.40100 day average+11.1%
$0.40200 day average+11.1%
$0.3920 day average+8.3%
$0.37Pivot R1+2.8%
$0.36Pivot+0.0%
$0.36Last close
$0.35Pivot S1−2.8%
$0.35Swing low (Aug 24)−2.8%
$0.2352 week low−36.1%
Indicators
RSI (14)
43.81
Middle of its range
Neutral
MACD
-0.04
Above its signal line
Bullish
Stochastic
22.1
Middle of its range
Neutral
ADX (14)
35.4
Trending up
Williams %R
-81.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-26.9
Oversold below −100, overbought above 100
Neutral
Rate of change
−26.1%
Change over 10 sessions
Bearish
ATR (14)
$0.12
Typical daily range, 34.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for ENSC
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ENSC did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow ENSC usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for ENSCHow many large options trades hit ENSC, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in ENSC in the last 90 days.
From SEC Form 4 filings by ENSC's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ENSC is in one of them and how their past ENSC trades turned out.
Ensysce Biosciences is a pharmaceutical company based in La Jolla, California. It is developing pain medicines designed to reduce the risk of opioid misuse, abuse and overdose. Its lead candidate, PF614, is an oxycodone prodrug meant to provide pain relief while resisting abuse by injection, snorting and oral misuse. The company's product candidates are aimed at patients with acute or chronic pain and the prescribers who treat them.